An animal study into taurine supplementation found that the amino acid delayed the onset of autoimmune diabetes in
non-obese diabetic mice.
The effect of gestation and fetal mismatching on the development of autoimmune diabetes in
non-obese diabetic mice.
Not exact matches
They demonstrated that
non-obese diabetic (NOD)
mice treated with a specific (AID / RAD51) pathway inhibitor had larger populations of certain B cells that were capable of suppressing diabetogenic T cell responses, and greatly reduced T1D development, compared with untreated controls.
(a) Growth curves of primary tumors in
non-obese diabetic / severe combined immunodeficiency disease (NOD / SCID)
mice injected with 5 × 105 or 5 × 104 MDA - MB 231 and MDA - MB 231 F3 cells.